Nektar Therapeutics Gains New Life On Buyout Rumors & Atopic Dermatitis Breakthrough
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast Track status and solid cash reserves, investor optimism builds.
The Novavax Crisis Deepens: Why Shah Capital Wants Out Now!
Novavax faces pressure from a major shareholder Shah Capital to explore a sale as it struggles with weak revenue, poor execution, and fading relevance post-COVID-19.
DocGo’s Bold SteadyMD Acquisition Sends Shares Flying—What’s Next?
DocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as DocGo gains growth, profit potential, and key new leadership.
Mister Car Wash Just Got Bigger: What The Whistle Express Deal Means For Its Future!
Mister Car Wash expands in Texas with five new Whistle Express locations, strengthening its local network, boosting efficiency, and focusing on smarter, more strategic long-term growth.
IBM Beats Expectations but Falls as Investors Zero In on Slowing Cloud Growth
IBM shares took a dive on Thursday despite stronger-than-expected third-quarter earnings and revenue. Investors have turned their focus to signs of cooling growth in the company’s software and hybrid cloud businesses.
Stock Market Today: Stocks Rise as Oil Prices Surge and Earnings Roll In After Tesla’s Mixed Results
U.S. stocks rose on Thursday, fueled by a rebound in oil prices and fresh corporate earnings.
McEwen Grabs Canadian Gold: Can Tartan Lake Fuel Its 2030 Gold Ambitions?
McEwen Mining is acquiring Canadian Gold Corp. in an all-stock deal, adding the high-grade Tartan Lake project in Manitoba to its portfolio—a strategic move to boost output and advance its 2030 goals.